First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1-Reference-Cited by-同舟云学术

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1

Published:2018-11-14 Issue:11 Volume:13 Page:e0205139
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Stephenson Kathryn E.,Keefer Michael C.,Bunce Catherine A.,Frances Doreen,Abbink Peter,Maxfield Lori F.^ORCID,Neubauer George H.,Nkolola Joseph,Peter Lauren,Lane Christopher,Park Harriet^ORCID,Verlinde Carl,Lombardo Angela,Yallop Christopher,Havenga Menzo,Fast Patricia,Treanor John,Barouch Dan H.^ORCID

Funder

Bill and Melinda Gates Foundation

National Institute of Allergy and Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference16 articles.

1. Development of replication-competent viral vectors for HIV vaccine delivery;CL Parks;Current opinion in HIV and AIDS,2013

2. Principles and Practice of Infectious Diseases;JE Bennett,2010

3. Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization;LF Maxfield;Clin Vaccine Immunol. American Society for Microbiology,2015

4. Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses;K Loré;Journal of immunology,2007

5. Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys;H Li;Journal of virology,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broad sialic acid usage amongst species D human adenovirus;npj Viruses;2023-09-26

2. Broad sialic acid usage amongst species D human adenovirus.;2023-06-12

3. Broad sialic acid usage amongst species D human adenovirus;2023-03-21

4. Inactivated and Recombinant Influenza Vaccines;Plotkin's Vaccines;2023

5. Current GMP standards for the production of vaccines and antibodies: An overview;Frontiers in Public Health;2022-11-03